Parathyroid hormone

(Natpara®)

Natpara®

Drug updated on 11/10/2023

Dosage FormInjection (subcutaneous; 25 mcg, 50 mcg, 75 mcg, 100 mcg)
Drug ClassHormones
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.